Search research articles
Contact Us
Filters
Showing results (31-40 of 82) with videos related to
Page
of 9
Sort By:
Oncogene
|
August 8, 2002
Changes in WT1 splicing are associated with a specific gene expression profile in Wilms' tumour
Dominique Baudry, Marine Faussillon, Marie-Odile Cabanis, et al.
Journal of Global Oncology
|
December 4, 2019
Advanced Burkitt Lymphoma in Sub-Saharan Africa Pediatric Units: Results of the Third Prospective Multicenter Study of the Groupe Franco-Africain d'Oncologie Pédiatrique
Gabrielle C Bouda, Fousseyni Traoré, Line Couitchere, et al.
Journal of Global Oncology
|
September 6, 2019
Treatment of Wilms Tumor in Sub-Saharan Africa: Results of the Second French African Pediatric Oncology Group Study
Atteby Jean-Jacques Yao, Claude Moreira, Fousseyni Traoré, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2009
Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: a report from the French Society of Pediatric Oncology
Laurence Brugières, Helene Pacquement, Marie-Cecile Le Deley, et al.
Blood
|
November 30, 2006
Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients
Catherine Patte, Anne Auperin, Mary Gerrard, et al.
JCO Global Oncology
|
August 9, 2020
Pediatric Oncology Clinical Trials and Collaborative Research in Africa: Current Landscape and Future Perspectives
Jaques van Heerden, Mohamed Zaghloul, Anouk Neven, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2012
Advanced stage, increased lactate dehydrogenase, and primary site, but not adolescent age (≥ 15 years), are associated with an increased risk of treatment failure in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB LMB 96 study
Mitchell S Cairo, Richard Sposto, Mary Gerrard, et al.
Haematologica
|
March 1, 2015
Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective "Lymphomes Malins B" protocols. A Société Française des Cancers de l'Enfant study
Anne Jourdain, Anne Auperin, Véronique Minard-Colin, et al.
Blood
|
December 2, 2006
Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents
Mitchell S Cairo, Mary Gerrard, Richard Sposto, et al.
Journal of Pediatric Hematology/Oncology
|
April 9, 2008
SFCE (Société Française de Lutte contre les Cancers et Leucémies de l'Enfant et de l'Adolescent) recommendations for the management of tumor lysis syndrome (TLS) with rasburicase: an observational survey
Yves Bertrand, Françoise Mechinaud, Benoit Brethon, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 82) with videos related to
Sort By:
Page
of 9
Oncogene
|
August 8, 2002
Changes in WT1 splicing are associated with a specific gene expression profile in Wilms' tumour
Dominique Baudry, Marine Faussillon, Marie-Odile Cabanis, et al.
Journal of Global Oncology
|
December 4, 2019
Advanced Burkitt Lymphoma in Sub-Saharan Africa Pediatric Units: Results of the Third Prospective Multicenter Study of the Groupe Franco-Africain d'Oncologie Pédiatrique
Gabrielle C Bouda, Fousseyni Traoré, Line Couitchere, et al.
Journal of Global Oncology
|
September 6, 2019
Treatment of Wilms Tumor in Sub-Saharan Africa: Results of the Second French African Pediatric Oncology Group Study
Atteby Jean-Jacques Yao, Claude Moreira, Fousseyni Traoré, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2009
Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: a report from the French Society of Pediatric Oncology
Laurence Brugières, Helene Pacquement, Marie-Cecile Le Deley, et al.
Blood
|
November 30, 2006
Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients
Catherine Patte, Anne Auperin, Mary Gerrard, et al.
JCO Global Oncology
|
August 9, 2020
Pediatric Oncology Clinical Trials and Collaborative Research in Africa: Current Landscape and Future Perspectives
Jaques van Heerden, Mohamed Zaghloul, Anouk Neven, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2012
Advanced stage, increased lactate dehydrogenase, and primary site, but not adolescent age (≥ 15 years), are associated with an increased risk of treatment failure in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB LMB 96 study
Mitchell S Cairo, Richard Sposto, Mary Gerrard, et al.
Haematologica
|
March 1, 2015
Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective "Lymphomes Malins B" protocols. A Société Française des Cancers de l'Enfant study
Anne Jourdain, Anne Auperin, Véronique Minard-Colin, et al.
Blood
|
December 2, 2006
Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents
Mitchell S Cairo, Mary Gerrard, Richard Sposto, et al.
Journal of Pediatric Hematology/Oncology
|
April 9, 2008
SFCE (Société Française de Lutte contre les Cancers et Leucémies de l'Enfant et de l'Adolescent) recommendations for the management of tumor lysis syndrome (TLS) with rasburicase: an observational survey
Yves Bertrand, Françoise Mechinaud, Benoit Brethon, et al.
Page
of 9